Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation

ABSTRACT: surgery samples of patients at early and late timepoints of a pancreatectomy

ORGANISM(S): Homo sapiens

PROVIDER: GSE149181 | GEO | 2020/11/15

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation.

Project description:Enteric glial cells (EGC) modulate motility, maintain gut homeostasis, and contribute to neuroinflammation in intestinal diseases and motility disorders. Damage induces a reactive glial phenotype known as "gliosis", but the molecular identity of the inducing mechanism and triggers of "enteric gliosis" are poorly understood. We tested the hypothesis that surgical trauma during intestinal surgery triggers ATP release that drives enteric gliosis and inflammation leading to impaired motility in postoperative ileus (POI). ATP activation of a p38-dependent MAPK pathway triggers cytokine release and a gliosis phenotype in murine (and human) EGCs. Receptor antagonism and genetic depletion studies revealed P2X2 as the relevant ATP receptor and pharmacological screenings identified ambroxol as a novel P2X2 antagonist. Ambroxol prevented ATP-induced enteric gliosis, inflammation, and protected against dysmotility, while abrogating enteric gliosis in human intestine exposed to surgical trauma. We identified a novel pathogenic P2X2-dependent pathway of ATP-induced enteric gliosis, inflammation and dysmotility in humans and mice. Interventions that block enteric glial P2X2 receptors during trauma may represent a novel therapy in treating POI and immune-driven intestinal motility disorders.

| S-EPMC7799361 | biostudies-literature

A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-11-15 | GSE134943 | GEO

A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation

Project description:A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation

| PRJNA627597 | ENA

A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation

Project description:A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation

| PRJNA556856 | ENA

Purinergic signaling in enteric gliosis [Dataset EV2]

Project description:Postoperative ileus mouse model

2020-11-15 | GSE134942 | GEO

Purinergic signaling in enteric gliosis [Dataset EV1]

Project description:Enteric Glia treated with exATP

2020-11-15 | GSE134941 | GEO

IL-1-dependent enteric gliosis guides intestinal inflammation and dysmotility and modulates macrophage function.

Project description:Muscularis Externa Macrophages (ME-Macs) and enteric glial cells (EGCs) are closely associated cell types in the bowel wall, and important interactions are thought to occur between them during intestinal inflammation. They are involved in developing postoperative ileus (POI), an acute, surgery-induced inflammatory disorder triggered by IL-1 receptor type I (IL1R1)-signaling. In this study, we demonstrate that IL1R1-signaling in murine and human EGCs induces a reactive state, named enteric gliosis, characterized by a strong induction of distinct chemokines, cytokines, and the colony-stimulating factors 1 and 3. Ribosomal tagging revealed enteric gliosis as an early part of POI pathogenesis, and mice with an EGC-restricted IL1R1-deficiency failed to develop postoperative enteric gliosis, showed diminished immune cell infiltration, and were protected from POI. Furthermore, the IL1R1-deficiency in EGCs altered the surgery-induced glial activation state and reduced phagocytosis in macrophages, as well as their migration and accumulation around enteric ganglia. In patients, bowel surgery also induced IL-1-signaling, key molecules of enteric gliosis, and macrophage activation. Together, our data show that IL1R1-signaling triggers enteric gliosis, which results in ME-Mac activation and the development of POI. Intervention in this pathway might be a useful prophylactic strategy in preventing such motility disorders and gut inflammation.

| S-EPMC9374731 | biostudies-literature

Purinergic signaling in enteric gliosis [Dataset EV1]

Project description:Purinergic signaling in enteric gliosis [Dataset EV1]

| PRJNA556859 | ENA

Purinergic signaling in enteric gliosis [Dataset EV2]

Project description:Purinergic signaling in enteric gliosis [Dataset EV2]

| PRJNA556860 | ENA

Il-1-dependent enteric gliosis guides intestinal inflammation and dysmotility and modulates macrophage function

Project description:IL-1 signaling in enteric glia initiates acute intestinal inflamation and modulates postoperative motility disturbances by triggering a reactive glial phenotype named enteric gliosis. Enteric glia modulate macrophage function and activity in this reactive state by releasing a unique panel of chemokines and cytokines. An enteric glia-selective knockout of this pathway ameliorates acute postoperative inflammation and prevents postoperative ileus.

2022-07-11 | GSE205610 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data